HELZ2はApoB mRNAの安定性を調節し,脂肪肝および動脈硬化症を調節する
Yiao Jiang1,2, Zhao Zhang1,2
1Center for the Genetics of Host Defense (Y.J., Z.Z.), University of Texas Southwestern Medical Center, Dallas.
Circulation
|December 25, 2025
まとめ
HELZ2はアポリポプロテインB (apoB) のmRNAの安定性と脂質代謝を調節する. HELZ2の調節は,心血管疾患と代謝機能障害に関連した脂肪性肝疾患の潜在的な治療法を提供します.
科学分野:
- 生物化学
- 遺伝学
- 代謝疾患の研究
背景:
- アポリポプロテインB (apoB) はリポプロテインの代謝に不可欠であり,心血管疾患と肝臓疾患に関連しています.
- APOBのmRNAの安定性の調節は,apoBのタンパク質分解とは異なり,ほとんど研究されていない.
研究 の 目的:
- APOB mRNAの安定性と脂質代謝の調節におけるHELZ2 (亜鉛指2を持つヘリカーゼ) の役割を調査する.
- 代謝および心血管疾患に対する HELZ2 調節の治療の可能性を調査する.
主な方法:
- 脂肪代謝のレギュレータを特定するためにマウスの遺伝子スクリーンを転送します.
- 異なる食事のマウスのHELZ2変異と欠乏の評価
- HELZ2がAPOBmRNAと結合し,その分解活性について評価.
- HELZ2が動脈硬化に及ぼす効果をApoe-/-およびLdlr-/-マウスモデルで調べた.
主要な成果:
- HELZ2 (Colby) の機能増強変異は,APOB mRNAのHELZ2の分解を強化することによって,肝臓の脂質蓄積を増加させる.
- HELZ2欠乏症は,高脂肪食でAPOB mRNAが増加し,トリグリセリドが減少する.
- 肝臓特異的なHELZ2誘導はColby現象型を模倣し,APOB mRNAを減少させ,脂質の取り扱いを変化させます.
- コルビーの変異は,マウスモデルにおける動脈硬化から保護します.
結論:
- HELZ2はAPOB mRNAの安定性と肝臓の脂質代謝の重要な調節剤である.
- 心血管疾患と代謝機能不全に関連した脂肪性肝疾患の治療には,HELZ2活性をターゲットにすることが有望である.
関連する概念動画
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Lipid Catabolism
804
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
804
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Regulation of Metabolism
11.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.3K
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K


